Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Mr Lozano, Addendum
Reply New Message
Back To Forum List View
Re: Mr Lozano
5
milestone
Aug 21, 2010 05:50PM

Thus, under the Rule as amended, a

shareholder proposal that would allow for shareholder use of the company’s proxy

materials to nominate director candidates, such as the proposal at issue in

AFSCME v. AIG

would be excludable. We believe the actions we are taking today will provide

certainty in the application of Rule 14a-8(i)(8) and will preserve our longstanding

interpretation of the Rule

http://www.sec.gov/rules/final/2007/34-56914.pdf

.

.

.

Be well

5 Recommendations
Re: Mr Lozano, In conclusion
5
milestone
Aug 21, 2010 06:28PM
Re: Response to PTSC Request for Exclusion of Stockholder Proposal
1
Mark4321
Aug 21, 2010 06:28PM
Re: Response to PTSC Request for Exclusion of Stockholder Proposal
1
Mark4321
Aug 21, 2010 06:47PM
Re: Response to PTSC Request for Exclusion of Stockholder Proposal
7
milestone
Aug 21, 2010 07:13PM
Re: Mr Lozano, In conclusion
1
Mark4321
Aug 21, 2010 07:39PM
Re: Response to PTSC Request for Exclusion of Stockholder Proposal
2
Mark4321
Aug 21, 2010 07:58PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply